Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell's CardioMetabolic and Pre-Diabetes panels offer definitive diagnostic and clinically relevant evaluation to help define risk of atherosclerotic cardiovascular disease (ASCVD) and progression toward type 2 diabetes. These check points along with an overall pre-diabetes risk score, help patients understand that not just one factor, but rather a constellation of risk factors, contribute to the genesis and progression toward poor blood sugar control and/or ASCVD. Results of testing allow doctors to know when guidance, educational referral, or treatment is necessary.
Sign up today and recieve 10% OFF
Use Code SAVE10 at Check out!